Search clinical trials for: Farnesoid X Receptor

Total 46525 results

Eli Lilly and Company

Completed

A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation

Sepsis | Hematologic Neoplasms | Infection | Hematopoietic Stem Cell Transplantation

United States
Sanofi

Completed

Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension

Hypertension

Taiwan
Università degli Studi dell'Insubria

Unknown

Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus Lercanidipine

HIV Infections | Hypertension

Italy
University of Alberta
Novartis

Completed

The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction

Refractory Ascites | Type 2 Hepatorenal Syndrome

Canada
Eli Lilly and Company

Completed

The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis at a Low Risk of Death

Sepsis

Canada, Finland, Belgium, Argentina, Chile, Australia, Austria, Brazil, Czech Republic, Denmark, Egypt, France
Sanofi

Completed

STILDEP: Zolpidem in Depressive and Dysthimic Patients

Depression | Sleep Initiation and Maintenance Disorders

Hungary
Eli Lilly and Company

Completed

An Open Label Study of Severe Sepsis in Adults

Severe Sepsis

Belgium
Affective Neuroscience Laboratory
Massachusetts General Hospital

Completed

The Effects of Acute Administration of Bupropion on Neural Substrates Underlying Hedonic Capacity

Major Depressive Disorder

United States
Walter Reed Army Medical Center

Unknown

Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty

Ocular Hypertension | Glaucoma

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B

Hemophilia B | Allergic Reactions

France, Italy, United States, Austria, Belgium, Spain, United Kingdom, Canada, Germany
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R) in Moderate to Severe Hemophilia B

Hemophilia B
Boston Children's Hospital
National Institutes of Health (NIH); Crohn's and Colitis Foundation

Completed

Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease

Crohn's Disease | Ulcerative Colitis

United States
Singapore National Eye Centre
Allergan

Unknown

Comparison of Bimatoprost and Latanoprost in Patients With Chronic Angle-Closure Glaucoma: A Randomized Cross-Over Study

Glaucoma, Angle-Closure

Singapore
Sheba Medical Center

Unknown

Adipokines as Predictors of the Metabolic Syndrome in ALL Survivors

Leukemia | Metabolic Syndrome X
Centre Hospitalier Universitaire de Nice

Completed

Cryptorchidism: Impact of in Utero Exposure to Xenobiotics With Hormonal Action

Cryptorchidism
Novartis

Completed

Single Dose Study to Assess the Safety, Tolerability, Concentration in Body and Effect of BAF312

Healthy

United States
Abbott

Completed

A Long Term Safety Study With Atrasentan

Adenocarcinoma | Prostate Cancer

Canada, United States, France, Netherlands, United Kingdom
Handok Inc.

Completed

Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study

Prostatic Hyperplasia

Korea, Republic of
University Hospital, Strasbourg, France

Completed

Prevention Trial of Nosocomial Infections in Neutropenic Prematures With G-CSF

Neutropenia in Prematures

France
Sanofi
Bristol-Myers Squibb

Completed

Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice

Hypertension

Tunisia
Johann Wolfgang Goethe University Hospital
German Federal Ministry of Education and Research

Unknown

Gene Therapy for Chronic Granulomatous Disease (CGD)

Granulomatous Disease, Chronic

Germany
Sanofi
Bristol-Myers Squibb

Completed

The Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Mild Hypertension

Hypertension

United States
Sanofi
Bristol-Myers Squibb

Completed

Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With Microalbuminuria (PRIME)

Hypertension
Hospital Clinic of Barcelona

Completed

Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C

Chronic Hepatitis C | Liver Fibrosis
Johannes Gutenberg University Mainz
AstraZeneca

Completed

Change of Inspiratory Peak Flow in COPD

Chronic Obstructive Pulmonary Disease

Germany
Shanghai Jiao Tong University School of Medicine

Completed

Adiponectin in Obese Women With T2DN and Effects by RAS Blocker

Diabetic Nephropathy | Type 2 Diabetes | Obese | Glucose Metabolism | Angiotensin II Type 1 Receptor Blockers
German Heart Institute
Charite University, Berlin, Germany; Merck Sharp & Dohme LLC

Unknown

PPARgamma Activation by Losartan in Hypertensive Patients: The Importance of Losartan-Metabolites

Hypertension

Germany
National Institute of Allergy and Infectious Diseases...
Johns Hopkins Bloomberg School of Public Health

Completed

Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults

Virus Diseases | Influenza

United States
Vancouver General Hospital
University of British Columbia

Unknown

Coronary Computed Tomographic Angiography in Emergency Department Chest Pain Patients at Intermediate Risk of Acute Coronary Syndrome (CCTA)

Coronary Disease | Acute Coronary Syndrome | Coronary Stenosis | Acute Myocardial Infarction | Unstable Angina

Canada
St. Louis University
Hoffmann-La Roche

Completed

Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)

Hepatitis | Fatty Liver

United States
Abbott
Orion Corporation, Orion Pharma

Completed

Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure.

Acute Heart Failure

United States
Eli Lilly and Company

Completed

Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis

Sepsis

United States, United Kingdom, France, Slovakia, Switzerland, Australia, Poland, Italy, Chile, Germany, Mexico
Maastricht University
Medtronic

Completed

Dutch National ITB Study in Children With Cerebral Palsy

Cerebral Palsy | Spasticity

Netherlands
Danish Pain Research Center

Completed

Neuropathic Pain and Fabry Disease

Fabry Disease

Denmark
National Health Research Institutes, Taiwan
Mackay Memorial Hospital; Taipei City Hospital; Department of Health Yuli Hospital

Unknown

Pharmacogenetic Profiling of Antipsychotics-Induced X-Syndrome and Diabetes (PAXD)

Diabetes | Metabolic Syndrome

Taiwan
University Hospital, Basel, Switzerland

Completed

Dental Safety Profile of High-Dose Radioiodine Therapy

Thyroid Cancer

Switzerland
Deutsches Herzzentrum Muenchen
Technical University of Munich

Completed

75 or 150 mg Clopidogrel Maintenance Doses Following PCI (ISAR-CHOICE-2)

Coronary Disease

Germany
Epix Pharmaceuticals, Inc.

Completed

A Efficacy Study of PRX-00023 in Patients With Major Depressive Disorder

Major Depressive Disorder (MDD)

United States
Associacio catalana per a la recerca oncologica...
Hoffmann-La Roche

Unknown

XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma

Rectal Neoplasms | Locally Advanced Rectal Adenocarcinoma

Spain
University Magna Graecia

Completed

Second-Line Treatments for Anovulatory Infertility in PCOS Patients

Polycystic Ovary Syndrome | Infertility | Anovulation

Italy
James A. Haley Veterans Administration Hospital
Hoffmann-La Roche

Terminated

Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma

Colorectal Cancer

United States
James A. Haley Veterans Administration Hospital
Hoffmann-La Roche

Terminated

Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma

Cancer of Liver

United States
Encysive Pharmaceuticals

Completed

Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension

Pulmonary Hypertension

United States
Institut de Recherches Cliniques de Montreal

Terminated

Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes

Hypertension | Type 2 Diabetes | Albuminuria

Canada
University of Mississippi Medical Center

Completed

Advanced Grandparental Age as a Risk Factor for Autism

Autistic Disorder | Rett Syndrome | Asperger Syndrome | Pervasive Developmental Disorder | Childhood Disintegrative Disorder

United States
Imperial College London

Unknown

Pharmacological vs Surgical Treatment for Mixed Incontinence

Urinary Incontinence, Stress | Urinary Incontinence, Urge | Mixed Urinary Incontinence

United Kingdom
Eli Lilly and Company

Completed

Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia

Schizophrenia

United States, Puerto Rico
Thrasher Research Fund
Centers for Disease Control and Prevention

Completed

Use of OraQuick for Screening HIV in Children Less Than Eighteen Months Old

HIV Antibody Testing

Zambia
Centre National de Greffe de Moelle Osseuse

Unknown

Trial of Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation

Graft vs Host Disease

Tunisia
Hadassah Medical Organization
XTL Biopharmaceuticals

Withdrawn

Safety, Tolerability and Efficacy of XTL 2125 in HCV-Infected Patients Who Are Interferon-Alpha Non-Responders or Relapsers

Chronic Hepatitis C Virus Infection

Israel

Search clinical trials for: Farnesoid X Receptor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations